p95HER2 tumors resistant to trastuzumab..

[Jean]

I am getting tired of each article starting off with "Her2 has a worse than average prognosis" Can't wait for the day when the "NEW" stats will
show that we are gaining ground!

http://www.medicalnewstoday.com/medicalnews.php?newsid=68166&nfid=al

Jean

[Christine MH-UK]

If they know that women with the shortened form of her2 seem to benefit most, perhaps they will use this knowledge when they do the trials.